Pfizer submits data to FDA for authorization of Covid vaccine booster shot for general population

Pfizer and BioNTech said they have submitted early stage clinical trial data to the FDA as part of their application seeking U.S. OK of a Covid booster shot.

from International: Top News And Analysis https://ift.tt/3soGkIN